Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,230 | -53,533 | -26,668 | -8,193 | 1,873 |
| Depreciation Amortization | 803 | 2,158 | 1,230 | 5,510 | 3,975 |
| Accounts receivable | -3,050 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -4,502 | N/A | N/A | N/A | N/A |
| Other Working Capital | -16,090 | 42,907 | 28,642 | -34,732 | -20,205 |
| Other Operating Activity | 11,693 | 1,006 | 65 | 2,177 | 1,856 |
| Operating Cash Flow | $-35,377 | $-7,462 | $3,269 | $-35,238 | $-12,501 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,109 | N/A | N/A | N/A | N/A |
| PPE Investments | -66 | -423 | -305 | -218 | -337 |
| Other Investing Activity | -126 | 10,378 | 1,309 | 22,547 | 69 |
| Investing Cash Flow | $7,917 | $9,955 | $1,004 | $22,329 | $-268 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -5,059 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 16,951 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -6,501 | -4,660 | -2,128 | -1,359 |
| Financing Cash Flow | $11,892 | $-6,501 | $-4,660 | $-2,128 | $-1,359 |
| Exchange Rate Effect | 1,160 | -546 | -277 | 297 | 158 |
| Beginning Cash Position | 75,373 | 76,402 | 76,035 | 91,157 | 91,839 |
| End Cash Position | 60,965 | 71,847 | 75,372 | 76,416 | 77,870 |
| Net Cash Flow | $-14,408 | $-4,555 | $-662 | $-14,741 | $-13,969 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,377 | -7,462 | 3,269 | -35,238 | -12,501 |
| Capital Expenditure | -66 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -35,443 | -7,462 | 3,269 | -35,238 | -12,501 |